KromaTiD Joins NIST Genome Editing Consortium

KromaTiD, Inc. announced today that it has joined the National Institutes of Standards and Technology Genome Editing Consortium, a newly launched public/private partnership ( The Consortium supports the emerging gene editing market and regulatory agency needs for standardized measurements of gene edits, editing by-products and the risks of utilizing genome editing technologies in research, commercial and therapeutic products.